Germany: Leaked Pricing Measures Could Have ‘Drastic’ Consequences For Orphans
Executive Summary
'Dangerous’ new measures outlined in a leaked bill would be a disaster for orphan drugs and lead to companies opting out of the German market, says one industry executive.
You may also be interested in...
Germany To Honor Pledge To Cut Spending On Medicines
Germany looks set to introduce new measures to curb pharmaceutical spending, including higher mandatory rebates for outpatient drugs and combination products. It will also lower the threshold at which orphan drugs must undergo a benefit assessment.
Advanced Therapies: Payment Revolution Must Accompany Industrial Revolution In Europe
The advanced therapies sector is undergoing something of an industrial revolution, but access issues for products coming to market remain, says Miguel Forte, CEO of Bone Therapeutics. However, there are opportunities to create a better environment for the sector, including regulatory change and more harmonization of HTA processes.
Latin American Countries To Coordinate Purchase Of Monkeypox Vaccine
Member states of the Pan American Health Organization have approved a resolution to combine purchasing power to buy monkeypox vaccines.